Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2.

Iain B McInnesSoumya D ChakravartyIsabel ApaolazaShelly KafkaElizabeth C HsiaYin YouArthur Kavanaugh

Published in: RMD open (2019)

Ustekinumab-treated patients demonstrated greater clinical response at week 24 compared with placebo regardless of prior treatment exposure and PsA disease duration.

Keyphrases

prostate cancer
newly diagnosed
rheumatoid arthritis
ejection fraction
combination therapy
machine learning
big data
electronic health record
patient reported outcomes
radical prostatectomy
artificial intelligence